Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-1 and Oxaliplatin in Locally Advanced Gastric Cancer
NCT01090505Phase 2Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Nov 2009
- Primary completion
- Dec 2012
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of tegafur, oxaliplatin in gastric adenocarcinoma, sponsored by Chinese PLA General Hospital. Status: unknown.
02
Drugs
tegafuroxaliplatin
03
Conditions
gastric adenocarcinoma
Beyond the preview
Go deeper on NCT01090505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01090505.